Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer TOKYO and NEW YORK, November...Read More
The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research
LOS ANGELES, Calif., October 24, 2023 – The Prostate Cancer Foundation (PCF) today announced the Class of 2023 Young Investigator Award recipients totaling $6.1 million in funding for innovative prostate...Read More
The Prostate Cancer Foundation Challenges America To Get Healthy This September
LOS ANGELES, Calif., August 31, 2023 – September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining...Read More
MLB commemorates Father’s Day in partnership with Prostate Cancer Foundation
For its 27th season, MLB and PCF has teamed up to host the Home Run Challenge. Each home run hit in all games beginning May 20 and leading up to...Read More
ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO
Washington, D.C., June 8, 2023 - After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7. Bugler, a...Read More
Major League Baseball and Prostate Cancer Foundation Partner on 27th Annual Home Run Challenge and Tour
LOS ANGELES, Calif., May 31, 2023 – The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are teaming up for the 27th Annual Home Run Challenge and Tour now...Read More
Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer
LOS ANGELES, Calif., May 24, 2023 – A team of Prostate Cancer Foundation (PCF)-funded researchers found that U.S. Veterans with cancer who receive in-person genetics counseling versus a telehealth consult...Read More
Prostate Cancer Foundation-Funded Research Identifies Promising Precision Immunotherapy Approach for Advanced Prostate Cancer
LOS ANGELES, Calif., April 5, 2023 – Although immunotherapies can successfully treat many types of cancer, they have shown limited effectiveness in advanced prostate cancer that has become resistant to...Read More
Hawks Raise $144,000 for Fifth Annual ‘Black History Month Assist Challenge’ to Support the Prostate Cancer Foundation
FOR IMMEDIATE RELEASE: 3/3/23 CONTACT: Max Strauss or Malynda Washington, Hawks Brand Communications, [email protected] More than $777,000 Donated to the Prostate Cancer Foundation Since the Launch of Campaign in 2019...Read More
Prostate Cancer Foundation-Funded Genetic Study of Men of African Ancestry Finds New Risk Factors for Prostate Cancer
The largest-ever genetic study of prostate cancer in Black men identified nine new gene variants that increase risk, determined polygenic risk score can predict more aggressive disease. LOS ANGELES, Calif.,...Read More
- 1
- 2